Leerink Partners Starts Dicerna Pharmaceuticals (DRNA) at Outperform
Leerink Partners analyst Mani Foroohar initiates coverage on Dicerna Pharmaceuticals ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)